OptimizeRx Corporation (OPRX)
NASDAQ: OPRX · Real-Time Price · USD
4.910
+0.160 (3.37%)
Dec 20, 2024, 4:00 PM EST - Market closed
OptimizeRx Stock Forecast
Stock Price Forecast
The 6 analysts with 12-month price forecasts for OptimizeRx stock have an average target of 8.25, with a low estimate of 5.00 and a high estimate of 16. The average target predicts an increase of 68.02% from the current stock price of 4.91.
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for OptimizeRx stock from 6 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Jul '24 | Aug '24 | Sep '24 | Oct '24 | Nov '24 | Dec '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 4 | 1 | 1 | 1 | 2 | 2 |
| Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Hold | 1 | 1 | 1 | 1 | 1 | 2 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 7 | 4 | 4 | 4 | 5 | 6 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Stephens & Co. | Stephens & Co. | Hold Initiates $5.5 | Hold | Initiates | $5.5 | +12.02% | Dec 20, 2024 |
| JMP Securities | JMP Securities | Buy Maintains $16 → $8 | Buy | Maintains | $16 → $8 | +62.93% | Nov 14, 2024 |
| RBC Capital | RBC Capital | Buy Maintains $14 → $7 | Buy | Maintains | $14 → $7 | +42.57% | Nov 14, 2024 |
| Roth MKM | Roth MKM | Strong Buy Reiterates $20 → $16 | Strong Buy | Reiterates | $20 → $16 | +225.87% | Nov 14, 2024 |
| Stifel | Stifel | Strong Buy Maintains $13 → $8 | Strong Buy | Maintains | $13 → $8 | +62.93% | Nov 14, 2024 |
Financial Forecast
Revenue This Year
91.13M
from 71.52M
Increased by 27.42%
Revenue Next Year
102.04M
from 91.13M
Increased by 11.97%
EPS This Year
0.29
from -1.03
EPS Next Year
0.35
from 0.29
Increased by 21.21%
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | 94.7M | 111.1M | 108.0M |
| Avg | 91.1M | 102.0M | 104.9M |
| Low | 86.2M | 93.1M | 100.8M |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | 32.4% | 21.9% | 5.8% |
| Avg | 27.4% | 12.0% | 2.8% |
| Low | 20.6% | 2.2% | -1.3% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | 0.34 | 0.49 | 0.40 |
| Avg | 0.29 | 0.35 | 0.39 |
| Low | 0.24 | 0.20 | 0.37 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | - | 71.0% | 14.1% |
| Avg | - | 21.2% | 10.8% |
| Low | - | -32.1% | 6.5% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.